About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Houston | 22,486 Studies Near You

Clinical TrialsHouston

Clinical Trials in Houston

Discover 22,486 clinical trials near Houston, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3041-3060 of 22,486 trials

Active not recruitingVenetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaThis phase II trial studies how well venetoclax and acalabrutinib work in treating patients with mantle cell lymphoma that did not respond to previous treatment or has come back.NCT03946878·Houston, Texas CompletedPhase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue SarcomaThis is a randomized, open-label, multicenter, Phase 3 study comparing the efficacy and safety of eribulin with dacarbazine in subjects with advanced soft tissue sarcoma who have…NCT01327885·Tucson, Arizona and 118 others

Find Trials by Condition in Houston

Breast Cancerin Houston Lung Cancerin Houston Prostate Cancerin Houston Colorectal Cancerin Houston Melanomain Houston Leukemiain Houston Lymphomain Houston Pancreatic Cancerin Houston Ovarian Cancerin Houston Brain Cancerin Houston Diabetes

Data from ClinicalTrials.govTerms

CompletedAn Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in ChildrenTo evaluate the pharmacokinetics of intravenous ganciclovir in children (ages 3 months - 12 years).NCT00002015·Birmingham, Alabama and 7 others

TerminatedA Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic ApproachThe goal of this clinical research study is learn if a vaccine that contains the patient's own cancer cell immunoglobulin can shrink or slow the growth of Chronic Lymphocytic…NCT00038415·Houston, Texas

RecruitingA Study of Oral Nuvisertib (TP-3654) in Patients With MyelofibrosisThis study is a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of nuvisertib (TP-3654) in patients…NCT04176198·Birmingham, Alabama and 90 others

CompletedFoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)The overall objective of this study is to compare the performance of available oligomeric and phosphorylated a-synuclein assay in cerebrospinal fluid and blood.NCT03170063·Chicago, Illinois and 4 others

RecruitingNodal Radiation Therapy for Sentinel Lymph Node Positive MelanomaThis phase II trial seeks to determine the role of nodal radiation therapy after sentinel lymph node biopsy (SLNB) for patients with high risk sentinel lymph node positive…NCT04594187·Jacksonville, Florida and 2 others

CompletedPD, PK, and Safety of ALTO-203 in Patients With MDDThe goal of this clinical trial is to determine the pharmacodynamic effects of ALTO-203 in patients with MDD in a randomized, placebo-controlled, single-dose crossover treatment…NCT06391593·Tucson, Arizona and 14 others

CompletedA Study of Danoprevir Boosted With Low Dose Ritonavir in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Virus InfectionThis randomized, open-label, active-controlled, parallel-group study will evaluate the sustained virological response of danoprevir boosted with low dose ritonavir in combination…NCT01220947·La Jolla, California and 67 others

TerminatedThrombin Generation and Thromboelastography in Non-overt DICSepsis is the 13th most common cause of death in the United States, causing approximately 210,000 deaths per year.NCT00299949·Houston, Texas

UnknownPancreatic Cancer Genetic Epidemiology (PACGENE) StudyThe goal of this research study is to investigate the role of genes that may point to a higher risk of developing pancreatic cancer.NCT00526578·Houston, Texas

CompletedHomocysteine Study (HOST)The primary objective of this study is to test the hypothesis that administration of folate, pyridoxine (vitamin B6) and cyanocobalamin (vitamin B12) in high doses to patients…NCT00032435·Birmingham, Alabama and 36 others

CompletedPost Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLsThe purpose of this study is to collect safety and performance data on two approved intraocular lenses (IOLs).NCT07161635·Torrance, California and 4 others

Active not recruitingStudy of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in WaldenstromPart A of this study evaluates iopofosine I 131 (CLR 131) in patients with select B-cell malignancies (multiple myeloma( MM), indolent chronic lymphocytic leukemia (CLL)/small…NCT02952508·Los Angeles, California and 51 others

CompletedJAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid TumorsTo evaluate the safety and tolerability of JAB-3312 administered in investigational regimens in adult participants with advanced solid tumors.NCT04720976·Phoenix, Arizona and 14 others

RecruitingA Non-Randomized Open Label Clinical Trial Evaluating DermaBind TLThe purpose of this clinical evaluation is to collect patient outcome data and evaluate the efficacy, safety and tolerability of HealthTech DermaBind TL™ in patients with chronic…NCT07172893·DeLand, Florida and 9 others

RecruitingShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus TrastuzumabThis phase III trial compares 6 months of human epidermal growth factor receptor 2 (HER2)-targeted therapy to 12 months of HER2-targeted therapy for the treatment of HER2-positive…NCT06876714·Phoenix, Arizona and 701 others

CompletedRopinirole 0.25 mg Tablets Under Fasting ConditionsThe objective of this study was to compare the relative bioavailability of the test formulation of Ropinirole (TEVA Pharmaceuticals USA) with already marketed reference of Requip®…NCT00829504·Houston, Texas

Active not recruitingBiomechanics of Metastatic Defects in BoneThe purpose of this study is to monitor fracture risk associated with bone tumors in cancer patients.NCT02109952·Baltimore, Maryland and 7 others

TerminatedSU5416 in Treating Children With Recurrent or Progressive Brain TumorsRATIONALE: SU5416 may stop the growth of brain cancer cells by stopping blood flow to the tumor.NCT00006247·San Francisco, California and 8 others

PreviousPage 153 of 1125Next

in Houston

Heart Diseasein Houston